AI Summary
✦ ClarthaValuation Metrics
Trading 20.5% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.04). Confidence: 80%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
29.29
Current
33.41
Overvalued
31.17
Undervalued
23.37
5Y Average
19.37
Current
21.65
Overvalued
21.36
Undervalued
19.23
5Y Average
8.01
Current
8.95
Overvalued
8.83
Undervalued
7.95
Peers & Comparison
Sector: Healthcare
Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹22 CrMar 2026Latest net profit
₹7.73 CrMar 2026Latest EPS
₹1.06Mar 2026Net margin
50.8%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales + | 13.95 | 16.82 | 22.95 | 14.19 | 22.17 |
| Expenses + | 8.37 | 8.54 | 9.67 | 8.36 | 10.91 |
| Operating Profit | 5.58 | 8.28 | 13.28 | 5.83 | 11.26 |
| OPM % | 40.00% | 49.23% | 57.86% | 41.09% | 50.79% |
| Other Income + | 0.00 | 0.23 | 0.12 | 0.10 | 0.18 |
| Interest | 0.39 | 0.43 | 0.51 | 1.12 | 1.24 |
| Depreciation | 0.57 | 0.36 | 0.59 | 0.47 | 0.61 |
| Profit before tax | 4.62 | 7.72 | 12.30 | 4.34 | 9.59 |
| Tax % | 27.71% | 19.69% | 26.67% | 26.73% | 19.40% |
| Net Profit + | 3.35 | 6.21 | 9.03 | 3.18 | 7.73 |
| EPS in Rs | 0.55 | 1.01 | 1.47 | 0.52 | 1.06 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation Under Regulation 30 And Para B, Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At South Extension, New Delhi
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018